Arcturus Therapeutics
ARCT • NASDAQ
Arcturus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph E. Payne, with a market cap of $192.1M.
Market Cap$192.1M
Employees180.0
CEOJoseph E. Payne
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Arcturus Therapeutics FAQ
Common questions about Arcturus Therapeutics
Arcturus Therapeutics is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $7.5M.
Arcturus Therapeutics has approximately 180 employees.